Assyro AI
Back to Glossary
General

PART 820

PART 820 helps teams standardize terminology and improve decision traceability.

Usage Examples

  • PART 820 improved consistency across global submission planning documents.
  • PART 820 was included in the cross-functional regulatory decision log.
  • Program teams used PART 820 to align regulatory, quality, and clinical milestones.

What is PART 820?

PART 820 is used in regulated product development to connect strategy, execution, and documentation quality. Regulatory teams apply it to keep terminology, evidence packaging, and authority interactions consistent.

Regulatory Context

This term appears most often in general workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside 21 CFR 820.

FDAICHHealth Canada

When This Matters

  • PART 820 improved consistency across global submission planning documents.
  • PART 820 was included in the cross-functional regulatory decision log.
  • Program teams used PART 820 to align regulatory, quality, and clinical milestones.

Common Mistakes

  • Relying on generic terminology without mapping to the active jurisdiction context.
  • Skipping cross-links between terms, tools, and active regulatory references.
  • Failing to maintain a single source of truth for regulatory definitions internally.

Related Regulations

21 CFR 820

Frequently Asked Questions

PART 820 is a regulatory concept used to improve submission quality, compliance consistency, and decision traceability.

PART 820 improves consistency in decisions, documentation, and authority communication.

Weak execution of PART 820 often leads to avoidable deficiencies, rework, and slower authority review cycles.

Related Terms

Related Use Cases

Related Regulatory Intelligence

Related Actions

Sources & References

Agent CTA Background

Simplify PART 820 compliance